← Back to Search

Low-Carb High-Fat breakfast for Eating Habits

N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first 14 days and last 14 days of the study
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if eating a low-carb, high-fat breakfast can help people with Type 2 Diabetes manage their health better. They will follow this breakfast routine for several months. The goal is to see if this simple change can improve their overall health by keeping their blood sugar more stable.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 14 days and last 14 days of the study
This trial's timeline: 3 weeks for screening, Varies for treatment, and first 14 days and last 14 days of the study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Hemoglobin A1c at 12 weeks
Secondary study objectives
Change from Baseline Blood Lipids at 12 weeks
Change from Baseline Body Mass Index at 12 weeks
Change from Baseline Body weight at 12 weeks
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Low-Carb High-Fat BreakfastExperimental Treatment1 Intervention
Participants will follow a daily low carbohydrate high fat breakfast intervention for 3 months.
Group II: Low fat "Standard Care" Control BreakfastActive Control1 Intervention
Participants will follow a daily low fat "standard care" control breakfast intervention for 3 months.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,466 Previous Clinical Trials
2,485,363 Total Patients Enrolled
University of WollongongOTHER
8 Previous Clinical Trials
13,572 Total Patients Enrolled
~18 spots leftby Nov 2025